FDA Issues Final Guidance Regarding Dear Health Care Provider (DHCP) Letters

more+
less-
more+
less-
Explore:  FDA Healthcare

On January 23, 2014, the FDA announced in the Federal Register that it issued a final Guidance for Industry and FDA Staff entitled, “Dear Health Care Provider Letters: Improving Communication of Important Safety Information.”  The guidance provides specific recommendations on the content and format of DHCP letters that are sent by manufacturers or distributors to physicians and other Health Care Providers (HCPs) to communicate important new or updated safety information about (1) an important drug warning, (2) a change in prescribing information, or (3) a correction of misinformation in promotional labeling or advertising for a prescription drug or biologic product. The guidance also provides instructions regarding what should not be included in DHCP communications.  In addition, the agency advises that manufacturers or distributors should conduct, for the company’s use, an assessment of the letter’s impact on communicating new information to HCPs. 

Topics:  FDA, Healthcare

Published In: Health Updates, Science, Computers & Technology Updates

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© King & Spalding | Attorney Advertising

Don't miss a thing! Build a custom news brief:

Read fresh new writing on compliance, cybersecurity, Dodd-Frank, whistleblowers, social media, hiring & firing, patent reform, the NLRB, Obamacare, the SEC…

…or whatever matters the most to you. Follow authors, firms, and topics on JD Supra.

Create your news brief now - it's free and easy »